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Diabetes mellitus and cystic fibrosis 
S.J. Rose, E. Keegan 
Department ofPaediatrics, Heartlaruls Hospital, Birmingtu~m UK 
Aims Children with cystic fibrosis may develop Type 1 diabetes mell itus or cystic 
fibrosis related diabetes mellitus. Good control of diabetes is known to be vital to 
preserve pulmonary function and growth. It is therefore important to determine an 
accurate blood sugar profile ha order to construct an individualised inml in  regimen. 
Methods Children with fasting blood sugars greater than 7.1 mmol/ l  have an oral 
glucose tolerance test. I f  this reveals abnormal glucose tolerance then they have a 4 
day continuous glucose profi le uti l is ing a Min imed glucose monitor. The profile is 
repeated once the child is on insulin or i f  there is continuing deterioration ha 
pulmonary function or i f  steroids are introduced. 
Results Four or even eight point blood sugar profiles do not always give sufficient 
information about blood sugar levels to construct an adequate insulin regimen for 
children with CFRD. The results indicate significant fluctuations in blood sugars 
especially with overnight feeds that are not wel l  controlled on standard type 1 
diabetes insulin regimens. We now have CF chi ldren on a wide variety of insul in 
regimens. Overnight feeds otten require additional insulin, the addition of steroids 
requires a different regimen. 
CorwIusion Untreated or inadequately treated iabetes mellitus in children with CF 
can lead to reduction in growth and declining pulmonary function. The dietary 
requirements must cont inue so the insul in reg imen must adapt to these 
requirements. We have demonstrated that individual children with CFRD mad type 
1 diabetes have very different blood glucose profiles that were not obvious on 4 or 
8 point blood sugar estimations. The use of a 4 day continuous blood glucose profile 
has allowed us to individualise and monitor insulin regimens regardless of the 
dietary needs. We bel ieve that this helps improve the overall health of the individual 
child. 
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Prevalence of osteoporosis and osteopenia in children and 
adolescents with cystic fibrosis 
P. Nikolaidou 1, I. Loukou 2, E. Georgouli 1, I. Inglezos 2, T. Gemenis 2,A. Antoniou ~, 
S. Doudounakis 2 
~3 ~J Pediatric Department, University of Athens, 2Cystic Fibrosis Department, 
'Aghia Sophia' ChiMren's Hospital, Athens, 3Department of Radiology, University 
of Athens 
The aim of our study was to determine the prevalence of osteoporosis and 
osteopenia in CF children and adolescents and to ident it~ risk factors. 
Methods: We studied 54 CF patients (23 male and 31 female) aged 4 21 years (mean 
age 12.5 yrs). Seventeen of them were in pre pubertal mad 37 were in mid mad post 
pubertal stages of development. Al l  patients uffered from pancreatic insufficiency 
and were taking 20 btg oral vitamin D daily. Serum 25(OH)D levels were within 
normal imits ha all the patients (20.05+9.65 ng/ml),  but were lower than those of 
healthy controls (39.64+8.94 ng/ml). None of the patients had been taking oral 
corticosteroids. Eighteen out of 54 patients had FEVI< 50%. Forty f ive of the 54 
patients were cbronically infected with Ps. aeruginosa. BMD was measured at the 
lumbar spine by dual energy x ray absorptiometry. 
Results: Twenty two of the 54 patients (41%)  had osleoporosis and 18 out of 54 
patients (33%) had osteopenia. Osteopor osis was found in 41% of pre pubertal and 
in 40.5% of mid and post pubertal CF patients. Osteopenia was found in 29% of 
pre pubertal and in 35% of mid and post pubertal CF patients. In patients with 
F~VI>50% , osleopor osis was found ha 25% and osteopenia in 42%. In patients with 
FEVI<50%, osteoporosis was found ha 72% and osteopenia in 17%. Cbronic 
infection with Ps. aeruginosa was not found to be a r isk factor for reduced BMD.  
Conclusions: Osteopenia mad osleoporosis are common findings ha CF patients. 
Despite the adequate administration f vitamin D, semm 25(OH)D levels are lower 
in patients than ha controls. Patients mostly at r isk are those with reduced lung 
function. 
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Spontaneous and reactive hypoglycemia in patients with Cystic 
Fibrosis 
A. B attezzati,A. Rcechi, D. Cos~antini, V. Bennat o, G Romano, V. Dacc6, C. Colombo 
ICANS arm CF Center; Universita degli Studi di Milano, Milan, Italy 
Growth fai lure and diabetes (CFRD) are associated to anabolic defects ha Oyslic 
Fibrosis patients (CF). Insulin is choice therapy in CFRD and could be used to 
counteract nutritional decay and progression to CFRD in glucose intolerant patients 
(GI) but hypoglycemia could be a l imit ing factor. Postabsorptively many CFRD 
patients are normoglycemic and a subset of CF is spontaneously hypoglycemic. 
Aims. To evaluate frequency of spontaneous hypoglycemia, nd relate it to glucose 
tolerance and nutritional status 
Methods. 118 CF without known CFRD received yearly OGTF (149 studies, 1.27 
studies/patient) and nutritional status evaluation. 
Results. 15.3% of CF (12.1% of studies) had postabsotptive glucose 0PG) <60 mg/dl 
but 1 was GI and 1 was CFRD. In the whole series 18% of OGTr  showed GI mad 
18% CFRD. Results in 15 hypoglycemic (40 57 mg/dl, HYPO)  and 15 
normoglycemic normotolerant (CON) sex mad age pair matched CF (16.6+1.2yr, 
range 11 24) were: 
Gluccv~ (mg/dl) Insulin (pU/ml) HOMA Weight Height 
Bag max 120' ALTC bag max 120' ALTC IS z-~oot~ z-soot~ 
HYPO 51  180 113 10540 7 67 42 4550 53 06 05 
+1" ±11 ±12 ±1022 ~ ±2 ±10 ±10 ±614 ±38 ±03 ° ±04 
CON 80 163 97 6555 7 64 39 3650 48 01 01 
+1 +10 +7 +826 +2 +11 +11 +598 +24 +03 +03 
* p 004 and ~ p 0005 (t test) o ~eater ptopoltion of negative values, p 003 (~ test) 
The peak PG was similar to CON because of a marked increment in PG AUC. 7 
HYPO and 4 CON had reactive hypoglycemia (<64mg/dl). Insul in responses mad 
sensitivity were not different. More HYPO were underweight with a worse 
Shwachman score (58±3 vs 67±3, p~).04). 
Conclusions. Spontaneous hypoglycemia does not exclude GI or CFRD and is more 
frequently associated to nutritional status impairment suggesting an anabolic defect. 
316 
Bone mineral density in children with cystic fibrosis and the effect of 
vitamin D and calcium supplementation 
E. Ocenaskova 1, H. Vanicek 1, A. Jebava 9
~Department of Pediatrics, Charles University Hospital, Hradec Kralove, Czech 
Republic, 21nstitute ofClinical Biochemistry a m Diagnostics, Charles University 
Hospital, Hradec Kralove, Czech Republic 
Introduction: Low bone mineral density (BMD) is a relatively frequent f inding in 
individuals with cystic fibrosis (CF), particularly in adults. BMD might be related 
to vitamin D and calcium malabsorption, although the pathogenesis of low BMD in 
CF population is multifactorial. 
The aims of this study were to ascertain BMD in children with CF and to evaluate 
the effect of vitamin D and calcium supplementation. 
Methods: Antbr opometry data, dual energy X ray absotptiometry (DEXA) BMD of 
lumbar spine (L1 L4), calcium urinary excretion (fU Ca) were measured in 14 
patients (aged 5.2 13.7 years, mean 10.0 years, 9 male, 5 female). Calcium mad 
vitamin D supplementation were adjusted according to these data. The effect of 
treatment was evaluated after one year. 
Results: 
Baaefine 1 yeea fter 
rain nlmx mean rain nlmx mean 
BMD Z score 3.5 0.7 2.1 2.5 0.2 1.4 
fU Ca (mrnoF24h) 0.53 1.31 1.00 0.31 4.94 2.76 
Ergocalciferol supplementation (ILT/day) 800 40CO 3086 1600 8000 4400 
Calcium supplementation (mg/day) 0 0 500 214 
Conclusions: 1. Low BMD may be present in prepubertal CF patients despite of 
usually recommended vitamin D dosage. 2. Early detection of low BIVff) and 
consequent v i tamin D plus calc ium intervention may improve BIVff). 3. 
Measurement of calcium urinary excretion is an advisable, non invasive and cheap 
method for monitoring of vitamin D and calcium supplementation. 
